Aier Eye Hospital Group (300015) - Net Assets
Based on the latest financial reports, Aier Eye Hospital Group (300015) has net assets worth CN¥24.61 Billion CNY (≈ $3.60 Billion USD) as of March 2026. Net assets (also known as shareholders' equity or book value) represent the difference between a company's total assets (CN¥36.58 Billion ≈ $5.35 Billion USD) and total liabilities (CN¥11.97 Billion ≈ $1.75 Billion USD). This figure indicates the residual interest in the assets after deducting liabilities, essentially showing what would remain for shareholders if all assets were liquidated and all debts paid off. Check 300015 goodwill-adjusted equity ratio to evaluate the tangible quality of the company's equity base.
Key Net Assets Metrics
| Metric | Value |
|---|---|
| Current Net Assets | CN¥24.61 Billion |
| % of Total Assets | 67.28% |
| Annual Growth Rate | 30.44% |
| 5-Year Change | 91.41% |
| 10-Year Change | 629.15% |
| Growth Volatility | 79.85 |
Aier Eye Hospital Group - Net Assets Trend (2006–2025)
This chart illustrates how Aier Eye Hospital Group's net assets have evolved over time, based on quarterly financial data. See Aier Eye Hospital Group defensive interval ratio to measure how many days the company can operate on defensive assets alone.
Annual Net Assets for Aier Eye Hospital Group (2006–2025)
The table below shows the annual net assets of Aier Eye Hospital Group from 2006 to 2025. For live valuation and market cap data, see Aier Eye Hospital Group stock valuation.
| Year | Net Assets | Change |
|---|---|---|
| 2025-12-31 | CN¥23.40 Billion ≈ $3.42 Billion |
+7.27% |
| 2024-12-31 | CN¥21.81 Billion ≈ $3.19 Billion |
+8.93% |
| 2023-12-31 | CN¥20.02 Billion ≈ $2.93 Billion |
+13.68% |
| 2022-12-31 | CN¥17.62 Billion ≈ $2.58 Billion |
+44.10% |
| 2021-12-31 | CN¥12.22 Billion ≈ $1.79 Billion |
+14.76% |
| 2020-12-31 | CN¥10.65 Billion ≈ $1.56 Billion |
+51.68% |
| 2019-12-31 | CN¥7.02 Billion ≈ $1.03 Billion |
+17.65% |
| 2018-12-31 | CN¥5.97 Billion ≈ $873.46 Million |
+9.08% |
| 2017-12-31 | CN¥5.47 Billion ≈ $800.73 Million |
+70.52% |
| 2016-12-31 | CN¥3.21 Billion ≈ $469.58 Million |
+28.40% |
| 2015-12-31 | CN¥2.50 Billion ≈ $365.71 Million |
+21.24% |
| 2014-12-31 | CN¥2.06 Billion ≈ $301.63 Million |
+18.55% |
| 2013-12-31 | CN¥1.74 Billion ≈ $254.44 Million |
+10.83% |
| 2012-12-31 | CN¥1.57 Billion ≈ $229.58 Million |
+11.01% |
| 2011-12-31 | CN¥1.41 Billion ≈ $206.81 Million |
+8.00% |
| 2010-12-31 | CN¥1.31 Billion ≈ $191.49 Million |
+6.06% |
| 2009-12-31 | CN¥1.23 Billion ≈ $180.56 Million |
+370.96% |
| 2008-12-31 | CN¥261.99 Million ≈ $38.34 Million |
+13.50% |
| 2007-12-31 | CN¥230.83 Million ≈ $33.78 Million |
+53.90% |
| 2006-12-31 | CN¥149.98 Million ≈ $21.95 Million |
-- |
Equity Component Analysis
This analysis shows how different components contribute to Aier Eye Hospital Group's total equity over time. Equity components include common stock, retained earnings, additional paid-in capital, and other elements.
Equity Composition Insights
- Retained earnings have grown by 24081.1% over the analyzed period, indicating profitable operations and earnings retention.
Current Equity Component Breakdown (December 2025)
| Component | Amount | Percentage |
|---|---|---|
| Retained Earnings | CN¥10.87 Billion | 49.45% |
| Other Components | CN¥11.11 Billion | 50.55% |
| Total Equity | CN¥21.97 Billion | 100.00% |
Aier Eye Hospital Group Competitors by Market Cap
The table below lists competitors of Aier Eye Hospital Group ranked by their market capitalization.
| Company | Market Cap |
|---|---|
|
A.P.MOELL-M.B U.ADR 1/200
F:DP4H
|
$11.30 Billion |
|
Var Energi ASA
OL:VAR
|
$11.32 Billion |
|
Wuxi Lead Auto Equipment Co Ltd
SHE:300450
|
$11.32 Billion |
|
VERBUND AG
VI:VER
|
$11.32 Billion |
|
WinWay Technology Co. Ltd
TW:6515
|
$11.29 Billion |
|
Revvity Inc.
NYSE:RVTY
|
$11.29 Billion |
|
Hyundai Glovis
KO:086280
|
$11.28 Billion |
|
Shenzhen Kinwong Electronic Co Ltd
SHG:603228
|
$11.26 Billion |
Equity Growth Attribution
This analysis shows how different factors contributed to changes in Aier Eye Hospital Group's equity between the two most recent reporting periods.
Equity Growth Insights
- From 2024 to 2025, total equity changed from 20,714,588,364 to 21,973,668,008, a change of 1,259,079,644 (6.1%).
- Net income of 3,240,259,465 contributed positively to equity growth.
- Dividend payments of 1,525,456,939 reduced retained earnings.
- Other comprehensive income increased equity by 94,954,852.
- Other factors decreased equity by 550,677,734.
Equity Change Factors (2024 to 2025)
| Factor | Impact | Contribution |
|---|---|---|
| Net Income | CN¥3.24 Billion | +14.75% |
| Dividends Paid | CN¥1.53 Billion | -6.94% |
| Other Comprehensive Income | CN¥94.95 Million | +0.43% |
| Other Changes | CN¥-550.68 Million | -2.51% |
| Total Change | CN¥- | 6.08% |
Book Value vs Market Value Analysis
This analysis compares Aier Eye Hospital Group's book value (net assets) with its market value over time. The relationship between these values can provide insights into investor sentiment and company valuation.
Valuation Insights
- Current price-to-book ratio: 3.51x
- The company is trading at a significant premium to its book value, suggesting the market values its earnings potential, brand, or other intangibles highly.
- The price-to-book ratio has decreased from 338.33x to 3.51x over the analyzed period, indicating reduced market premium.
Historical Price-to-Book Ratios
| Date | Book Value per Share | Market Price | P/B Ratio |
|---|---|---|---|
| 2006-12-31 | CN¥0.02 | CN¥8.28 | x |
| 2007-12-31 | CN¥0.04 | CN¥8.28 | x |
| 2008-12-31 | CN¥0.05 | CN¥8.28 | x |
| 2009-12-31 | CN¥0.25 | CN¥8.28 | x |
| 2010-12-31 | CN¥0.21 | CN¥8.28 | x |
| 2011-12-31 | CN¥0.22 | CN¥8.28 | x |
| 2012-12-31 | CN¥0.19 | CN¥8.28 | x |
| 2013-12-31 | CN¥0.21 | CN¥8.28 | x |
| 2014-12-31 | CN¥0.25 | CN¥8.28 | x |
| 2015-12-31 | CN¥0.29 | CN¥8.28 | x |
| 2016-12-31 | CN¥0.36 | CN¥8.28 | x |
| 2017-12-31 | CN¥0.61 | CN¥8.28 | x |
| 2018-12-31 | CN¥0.65 | CN¥8.28 | x |
| 2019-12-31 | CN¥0.75 | CN¥8.28 | x |
| 2020-12-31 | CN¥1.10 | CN¥8.28 | x |
| 2021-12-31 | CN¥1.25 | CN¥8.28 | x |
| 2022-12-31 | CN¥1.84 | CN¥8.28 | x |
| 2023-12-31 | CN¥2.04 | CN¥8.28 | x |
| 2024-12-31 | CN¥2.24 | CN¥8.28 | x |
| 2025-12-31 | CN¥2.36 | CN¥8.28 | x |
Capital Efficiency Dashboard
This dashboard shows how efficiently Aier Eye Hospital Group utilizes its equity to generate returns, including Return on Equity (ROE) and its components based on the DuPont analysis framework.
Capital Efficiency Insights
- Current Return on Equity (ROE): 14.75%
- The company shows good efficiency in utilizing shareholder equity.
- DuPont Analysis Breakdown:
- • Net Profit Margin: 14.50%
- • Asset Turnover: 0.61x
- • Equity Multiplier: 1.67x
- Recent ROE (14.75%) is below the historical average (16.25%), suggesting potential challenges in capital efficiency.
Historical Capital Efficiency Metrics
| Year | Return on Equity | Net Profit Margin | Asset Turnover | Equity Multiplier | Economic Value Added |
|---|---|---|---|---|---|
| 2006 | 14.19% | 7.63% | 0.57x | 3.24x | CN¥4.31 Million |
| 2007 | 22.23% | 12.38% | 0.88x | 2.04x | CN¥21.45 Million |
| 2008 | 25.94% | 14.43% | 1.07x | 1.68x | CN¥37.71 Million |
| 2009 | 7.65% | 15.43% | 0.42x | 1.17x | CN¥-28.36 Million |
| 2010 | 9.42% | 13.91% | 0.54x | 1.26x | CN¥-7.39 Million |
| 2011 | 12.57% | 13.12% | 0.76x | 1.26x | CN¥35.17 Million |
| 2012 | 12.18% | 11.13% | 0.85x | 1.29x | CN¥32.64 Million |
| 2013 | 13.41% | 11.26% | 0.94x | 1.27x | CN¥56.89 Million |
| 2014 | 15.55% | 12.87% | 0.94x | 1.28x | CN¥110.34 Million |
| 2015 | 17.87% | 13.52% | 0.97x | 1.36x | CN¥188.50 Million |
| 2016 | 18.24% | 13.92% | 0.90x | 1.45x | CN¥251.68 Million |
| 2017 | 14.24% | 12.45% | 0.64x | 1.79x | CN¥220.91 Million |
| 2018 | 17.73% | 12.60% | 0.83x | 1.69x | CN¥439.81 Million |
| 2019 | 20.91% | 13.80% | 0.84x | 1.80x | CN¥719.52 Million |
| 2020 | 17.49% | 14.47% | 0.65x | 1.86x | CN¥738.42 Million |
| 2021 | 20.54% | 15.49% | 0.69x | 1.93x | CN¥1.19 Billion |
| 2022 | 15.14% | 15.67% | 0.61x | 1.59x | CN¥857.08 Million |
| 2023 | 17.81% | 16.49% | 0.67x | 1.60x | CN¥1.47 Billion |
| 2024 | 17.17% | 16.95% | 0.63x | 1.61x | CN¥1.48 Billion |
| 2025 | 14.75% | 14.50% | 0.61x | 1.67x | CN¥1.04 Billion |
Industry Comparison
This section compares Aier Eye Hospital Group's net assets metrics with peer companies in the Medical Care Facilities industry.
Industry Context
- Industry: Medical Care Facilities
- Average net assets among peers: $3,067,441,084
- Average return on equity (ROE) among peers: -0.91%
Peer Company Comparison
| Company | Net Assets | Return on Equity | Debt-to-Equity | Market Cap |
|---|---|---|---|---|
| Aier Eye Hospital Group (300015) | CN¥24.61 Billion | 14.19% | 0.49x | $11.30 Billion |
| Xian International Medical Investment Co Ltd (000516) | $3.33 Billion | 7.24% | 0.60x | $1.31 Billion |
| Meinian Onehealth Healthcare Holdings Co Ltd (002044) | $6.19 Billion | 7.29% | 0.46x | $2.89 Billion |
| Hengkang Medical Group Co Ltd (002219) | $2.86 Billion | -49.61% | 2.07x | $951.71 Million |
| Liaoning He Eye Hospital Group Co. LTD. (301103) | $2.07 Billion | 3.07% | 0.20x | $373.69 Million |
| Chengdu Bright Eye Hospital Co. Ltd. (301239) | $2.12 Billion | -4.80% | 1.17x | $721.63 Million |
| Huaxia Eye Hospital Group Co. Ltd. A (301267) | $6.02 Billion | 7.12% | 0.32x | $1.99 Billion |
| Sanbo Hospital Management Group Ltd. A (301293) | $1.38 Billion | 4.59% | 0.40x | $1.63 Billion |
| Top Choice Medical Investment Co Inc (600763) | $563.69 Million | 17.81% | 0.14x | $2.26 Billion |
About Aier Eye Hospital Group
Aier Eye Hospital Group Co., Ltd. operates as an ophthalmic medical company in China, Hong Kong, Europe, the United States, Europe, and Southeast Asia. It offers diagnosis and treatment of various ophthalmic diseases, surgical services, medical optometry, and lens fitting for fundus diseases, glaucoma, and cataract. The company also provides training courses for cataract cases, ICL surgery, and p… Read more